Air France-KLM SA engages in providing passenger and cargo air transportation services. The company is headquartered in Paris, Ile-De-France and currently employs 81,940 full-time employees. The firm is engaged in passenger transportation. Its activities also include cargo, aeronautics maintenance and other air-transport-related activities, including catering. The firm's two sub-groups Air France and KLM have a flyer program, Flying Blue, which enables members to acquire miles as they fly with airline partners or from transactions with non-airline partners. Its activities include Passenger transport, Cargo transport, Maintenance and Other activities. The firm's network is organized around the hubs at Paris-Charles de Gaulle and Amsterdam-Schiphol. With these two hubs, the Company links Europe to the rest of the world, with approximately 320 destinations in over 115 countries. Transavia, the Company's subsidiary, has operations in the Netherlands and France directed at medium-haul leisure customers, as well as through its charter flights and tour operators.
最新の財務諸表(Form-10K)によると、TriSalus Life Sciences Incの総資産は$0で、純損失は$0です。
AFRAFの主要な財務比率は何ですか?
TriSalus Life Sciences Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Air France-KLM SAの収益はセグメントまたは地域別にどのように分けられていますか?
TriSalus Life Sciences Inc の最大収益セグメントは Innovative Drug Delivery Technology and Immune-oncology Therapeutics で、最新の利益発表における収益は 18,511,000 です。地域別に見ると、United States が TriSalus Life Sciences Inc の主要市場であり、収益は 18,511,000 です。
Air France-KLM SAは収益を上げていますか?
いいえ、最新の財務諸表によると、TriSalus Life Sciences Incの純損失は$0です。